BAYRY News and Press, Bayer AG ADR From 01/08/24

2024-01-08 14:06:31 ET Disclosing its preliminary financials for Q4 2023, Regeneron Pharmaceuticals ( NASDAQ: REGN ) announced Monday that it intends to recognize ~$1.34B as U.S. net product sales from its blockbuster eye disease therapy Eylea during the quarter. Meanwhile, its ...

2024-01-07 03:02:50 ET Summary In December 2023 - January 2024, Barron’s/Fortune analysts-reporters combined to list three sets of stocks: (1) Top 100 of first-ever Euro Fortune 500; (2) 13 Inflation-Proof 2024 stocks; (3) Barron’s 10 Favorites for 2024. Those three ...

2024-01-06 07:15:00 ET Summary High dividend yield companies are essential components within a well-balanced and diversified dividend portfolio, particularly for those seeking to generate substantial additional income via dividends. In this article, I will present 10 high dividend...

2024-01-04 15:25:59 ET More on Recursion Pharmaceuticals Recursion Pharmaceuticals: Second Half 2024 Data Readouts Are Major Inflection Points Absci hits new 52-week high as race for AI drug discovery heats up Recursion Pharma spikes after 3.8M ARK buy Seekin...

2023-12-25 19:06:09 ET Summary William Nygren's 13F portfolio value decreased from $56.60B to $51.39B in Q3 2023. The portfolio is diversified with around 200 positions, with the largest five stakes being Alphabet, Charter Communications, Capital One Financial, Intercontinental Ex...

2023-12-23 22:50:39 ET More on Bayer AG Bayer Isn't Dead Breaking Up Bayer? Probably Not! Bayer Aktiengesellschaft 2023 Q3 - Results - Earnings Call Presentation Monsanto told to pay $857 million over PCBs at school in Washington Bayer divestiture of ...

2023-12-22 18:18:15 ET Summary Today, we revisit Bicycle Therapeutics plc, a UK-based clinical stage biotech company focused on developing medicines for underserved diseases. The company has inked two significant collaboration deals with large drug makers in 2023 and continues to ...

2023-12-22 17:56:28 ET Summary The biotech bear market has presented investment opportunities for investors to take meaningful stakes in public companies at venture valuations. AI drug discovery has faced setbacks in the past 18 months, but Gain Therapeutics' has found success usi...

2023-12-18 16:08:20 ET More on Bayer, Bayer AG, etc. Bayer Isn't Dead Breaking Up Bayer? Probably Not! Bayer Aktiengesellschaft 2023 Q3 - Results - Earnings Call Presentation Bayer divestiture of consumer health business would cause huge tax bill - report ...

2023-12-16 13:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of the biggest stories of the year has been the rise of AI in every industry. This trend will hit biotech stocks no less than any others. Already, cutting edge healthcare stocks ...